Insights

Notes from the field.

Market intelligence, compliance updates, and technical notes from our operating teams.

International Compliance & Quality Standards

DGDA
WHO-GMP
ISO 9001
GDP
GSDP
REACH

All articles

8 articles

ZDHC Level 3: What It Means for Bangladesh RMG Exporters in 2026
Regulatory & Compliance

ZDHC Level 3: What It Means for Bangladesh RMG Exporters in 2026

Major buyers now expect Level 3 conformance on the ZDHC Gateway. Here is the documentation trail, timeline, and factory playbook Inventa uses with textile partners.

6/17/2026 Dr. Farhana Sultana
Read featured article
Localized Buffer Stock: Eliminating Production Downtime in Industrial CorridorsOperations & Supply Chain

Localized Buffer Stock: Eliminating Production Downtime in Industrial Corridors

How strategic inventory positioning inside Ashulia, Gazipur, and Chattogram EPZ corridors protects manufacturers from port delays and supplier shocks.

5/27/2026Read
Entering Bangladesh as an International Chemical or Pharma InnovatorMarket Entry & Strategy

Entering Bangladesh as an International Chemical or Pharma Innovator

A field guide for foreign manufacturers evaluating MAH partnership, exclusive licensing, and on-ground commercial acceleration.

5/9/2026Read
MAH Registration in Bangladesh: What Foreign Manufacturers Must KnowPharmaceutical Insights

MAH Registration in Bangladesh: What Foreign Manufacturers Must Know

Marketing Authorization Holder obligations under DGDA — from dossier submission to post-market surveillance and import permissions.

4/21/2026Read
Cold-Chain Distribution Under GSDP: A Practical FrameworkOperations & Supply Chain

Cold-Chain Distribution Under GSDP: A Practical Framework

Temperature-controlled logistics for vaccines, biologics, and sensitive formulations — warehouse design, monitoring, and last-mile compliance.

4/4/2026Read
Navigating Letters of Credit for Chemical Imports into BangladeshTrade & Export

Navigating Letters of Credit for Chemical Imports into Bangladesh

How to structure L/C terms, documentation, and bank coordination for specialty chemical and pharma raw material shipments.

3/19/2026Read
Exclusive In-Licensing vs. Distributor Models: Choosing the Right StructureMarket Entry & Strategy

Exclusive In-Licensing vs. Distributor Models: Choosing the Right Structure

When to appoint an exclusive licensing partner versus a multi-distributor network — risk, margin, and control trade-offs for pharma principals.

2/13/2026Read
WHO-GMP Audits: Preparing Your Bangladesh Facility for 2026 InspectionsRegulatory & Compliance

WHO-GMP Audits: Preparing Your Bangladesh Facility for 2026 Inspections

Documentation systems, deviation trends, and data integrity — what DGDA and international auditors focus on during GMP inspections.

1/29/2026Read